Skip to main content
. 2020 Sep 25;34(3):856–866. doi: 10.1007/s12028-020-01110-2

Fig. 1.

Fig. 1

Temporal course of S100B, glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), and microtubule-associated protein tau (MAPT) in patients with a good outcome (Group 1) and in patients with a bad outcome (Group 2), based on the grade in the Glasgow Outcome Scale at discharge from the ICU. (*p < 0.05; **p < 0.001)